Les publications de Thomas RAPP
Higher Hospital Referral Concentration Associated with Lower Risk Patients in Skilled Nursing Facilities Are long-term care jobs harmful? Evidence from Germany. Health measures and long-term care use in the European frail population Frailty, sarcopenia, and long-term care utilization in older populations: a systematic review The contribution of the immigrant population to the U.S. long term care workforce Are frail elderly people in Europe high-need subjects? First evidence from the SPRINTT trial Heterogeneity in Drug Recommendation Compliance: Evidence from France of a Gender Bias in the Treatment of Alzheimer’s Patients The Dynamics of Frailty and Change in Socio-Economic Conditions: Evidence for the 65+ in Europe Frailty transitions and healthcare use in Europe. New evidence from SHARE data The impact of economic conditions on the disablement process: A Markov transition approach using SHARE data The Cost of Frailty in France The Dynamics of Hospital Use among Older People. Evidence for Europe using SHARE data The impact of institution use on the wellbeing of Alzheimer’s disease patients and their caregivers Quality of diabetes follow-up care and hospital admissions forthcoming Resource use and cost of Alzheimer’s disease in France: 18-month results from the GERAS observational study The impact of material conditions on the disablement process (Forthcoming) Genèse, bilan et futur de l’ObamaCare (forthcoming) La maladie d’Alzheimer, une affaire de famille Preventing frailty and autonomy loss in Europe: A health economics perspective from the SPRINTT study L’évaluation HTA simplifiée : perspectives pour la France The Dynamics of Hospital Use among Older People Evidence for Europe Using SHARE Data Exploring the determinants of endocrinologist visits by patients with diabetes Vieillissement, fragilité et dépenses de santé Effects of a long-term exercise program on functional ability in people with dementia living in nursing homes : Research protocol of the LEDEN study, a cluster randomised controlled trial The cost of frailty in France Les innovations « frugales », source de valeur pour nos systèmes de santé ? Dépenses de santé, vieillissement et fragilité : le cas français L’aide publique aux personnes âgées fragiles en situation de précarité financière : comparaison franco-américaine L’intégration des parcours de soins aux Etats-Unis : quels constats cinq ans après le lancement de l’ObamaCare ? Are public subsidies effective to reduce emergency care use ? Evidence from the PLASA study, Social Science and Medicine. An analysis of the public financial support eligibility rule for French dependent elders with Alzheimer’s disease, Value in Health. Preventing frailty and autonomy loss in Europe: A health economics perspective from the SPRINTT study, Aging Clinical and Experimental Research, Special Issue on frailty La fragilité : aspects économiques, in Repérage et maintien de l’autonomie des personnes âgées fragiles Patients’ diagnosis decisions in Alzheimer’s disease : The influence of family factors Health Economics Considerations in Neurodegenerative Disorders Comparison of informal care time and costs in different age-related dementias : a review, Accepted for publication, Journal of biomedicine and biotechnology Methodological considerations in Cost of Illness Studies on Alzheimer Disease Exploring the Relationship Between Alzheimer’s Disease Severity and Longitudinal Costs Public financial support receipt and non-medical resource utilization in Alzheimer’s disease -Results from the PLASA study Differences in Resource Use and Costs of Dementia Care Between European Countries : Baseline Data from the ICTUS Study Health Economics and Health Policy Issues in Alzheimer’s Disease
Back to Top
